Immunodeficiency and autoimmunity in H2-O-deficient mice

Journal of Immunology

Volumn 190, Issue 1, 2013, Pages 126-137

  Gu, Yapeng ^a   Jensen, Peter E ^a   Chen, Xinjian ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; DOUBLE STRANDED DNA; HISTONE; HLA DO ANTIGEN; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2A ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; OVALBUMIN; SINGLE STRANDED DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHIMERA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CELL LINE, TUMOR; H-2 ANTIGENS; HLA-D ANTIGENS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC;

EID: 84871834366     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200993     Document Type: Article

References (48)

1. Cresswell, P. 1994. Antigen presentation: getting peptides into MHC class II molecules. Curr. Biol. 4: 541-543.
2. Jensen, P. E., D. A.Weber, W. P. Thayer, X. Chen, and C. T. Dao. 1999. HLA-DM and the MHC class II antigen presentation pathway. Immunol. Res. 20: 195-205. (Pubitemid 30119567)
3. Alfonso, C., and L. Karlsson. 2000. Nonclassical MHC class II molecules. Annu. Rev. Immunol. 18: 113-142. (Pubitemid 30365376)
4. Chen, X., and P. E. Jensen. 2008. MHC class II antigen presentation and immunological abnormalities due to deficiency of MHC class II and its associated genes. Exp. Mol. Pathol. 85: 40-44.
5. Hsing, L. C., and A. Y. Rudensky. 2005. The lysosomal cysteine proteases in MHC class II antigen presentation. Immunol. Rev. 207: 229-241. (Pubitemid 41415021)
6. Weber, D. A., B. D. Evavold, and P. E. Jensen. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274: 618-620. (Pubitemid 26360442)
7. Vogt, A. B., S. O. Arndt, G. J. Ha? mmerling, and H. Kropshofer. 1999. Quality control of MHC class II associated peptides by HLA-DM/H2-M. Semin. Immunol. 11: 391-403. (Pubitemid 30047501)
8. Lazarski, C. A., F. A. Chaves, and A. J. Sant. 2006. The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHCpeptide kinetic stability. J. Exp. Med. 203: 1319-1328. (Pubitemid 43736600)
9. Denzin, L. K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82: 155-165.
10. Fung-Leung, W. P., C. D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P. A. Peterson, S. R. Webb, and L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science 271: 1278-1281. (Pubitemid 26082648)
11. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H. Ploegh, C. Benoist, and D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84: 531-541. (Pubitemid 26071734)
12. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84: 543-550. (Pubitemid 26071735)
13. Denzin, L. K., D. B. Sant'Angelo, C. Hammond, M. J. Surman, and P. Cresswell. 1997. Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 278: 106-109.
14. van Ham, S. M., E. P. Tjin, B. F. Lillemeier, U. Grüneberg, K. E. van Meijgaarden, L. Pastoors, D. Verwoerd, A. Tulp, B. Canas, D. Rahman, et al. 1997. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading. Curr. Biol. 7: 950-957. (Pubitemid 28017072)
15. Karlsson, L. 2005. DM and DO shape the repertoire of peptide-MHC-class-II complexes. Curr. Opin. Immunol. 17: 65-70. (Pubitemid 40094016)
16. Denzin, L. K., J. L. Fallas, M. Prendes, and W. Yi. 2005. Right place, right time, right peptide: DO keeps DM focused. Immunol. Rev. 207: 279-292. (Pubitemid 41415024)
17. Liljedahl, M., T. Kuwana, W. P. Fung-Leung, M. R. Jackson, P. A. Peterson, and L. Karlsson. 1996. HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport. EMBO J. 15: 4817-4824. (Pubitemid 26315792)
18. Liljedahl, M., O. Winqvist, C. D. Surh, P. Wong, K. Ngo, L. Teyton, P. A. Peterson, A. Brunmark, A. Y. Rudensky, W. P. Fung-Leung, and L. Karlsson. 1998. Altered antigen presentation in mice lacking H2-O. Immunity 8: 233-243. (Pubitemid 28123750)
19. van Ham, M., M. van Lith, B. Lillemeier, E. Tjin, U. Grüneberg, D. Rahman, L. Pastoors, K. van Meijgaarden, C. Roucard, J. Trowsdale, et al. 2000. Modulation of the major histocompatibility complex class II-associated peptide repertoire by human histocompatibility leukocyte antigen (HLA)-DO. J. Exp. Med. 191: 1127-1136.
20. Kremer, A. N., E. D. van der Meijden, M. W. Honders, J. J. Goeman, E. J. Wiertz, J. H. Falkenburg, and M. Griffioen. 2012. Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO. Blood 120: 3246-3255.
21. Yi, W., N. P. Seth, T. Martillotti, K. W. Wucherpfennig, D. B. Sant'Angelo, and L. K. Denzin. 2010. Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence. J. Clin. Invest. 120: 1324-1336.
22. Chen, X., O. Laur, T. Kambayashi, S. Li, R. A. Bray, D. A. Weber, L. Karlsson, and P. E. Jensen. 2002. Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development. J. Exp. Med. 195: 1053-1062. (Pubitemid 34412007)
23. Hornell, T. M., T. Burster, F. L. Jahnsen, A. Pashine, M. T. Ochoa, J. J. Harding, C. Macaubas, A. W. Lee, R. L. Modlin, and E. D. Mellins. 2006. Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation. J. Immunol. 176: 3536-3547. (Pubitemid 43364001)
24. Chen, X., L. M. Reed-Loisel, L. Karlsson, and P. E. Jensen. 2006. H2-O expression in primary dendritic cells. J. Immunol. 176: 3548-3556. (Pubitemid 43364002)
25. Jensen, P. E. 1998. Antigen processing: HLA-DO-a hitchhiking inhibitor of HLA-DM. Curr. Biol. 8: R128-R131. (Pubitemid 28126605)
26. Haas, C., B. Ryffel, and M. Le Hir. 1997. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J. Immunol. 158: 5484-5491. (Pubitemid 127681257)
27. Goodnow, C. C. 2007. Multistep pathogenesis of autoimmune disease. Cell 130: 25-35. (Pubitemid 47031326)
28. Perraudeau, M., P. R. Taylor, H. J. Stauss, R. Lindstedt, A. E. Bygrave, D. J. Pappin, S. Ellmerich, A. Whitten, D. Rahman, B. Canas, et al. 2000. Altered major histocompatibility complex class II peptide loading in H2-Odeficient mice. Eur. J. Immunol. 30: 2871-2880.
29. Jameson, S. C. 2002. Maintaining the norm: T-cell homeostasis. Nat. Rev. Immunol. 2: 547-556. (Pubitemid 37328730)
30. Ernst, B., D. S. Lee, J. M. Chang, J. Sprent, and C. D. Surh. 1999. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity 11: 173-181. (Pubitemid 29428810)
31. Clarke, S. R., and A. Y. Rudensky. 2000. Survival and homeostatic proliferation of naive peripheral CD4+ T cells in the absence of self peptide:MHC complexes. J. Immunol. 165: 2458-2464. (Pubitemid 30660690)
32. Hardy, R. R., Y. S. Li, D. Allman, M. Asano, M. Gui, and K. Hayakawa. 2000. B-cell commitment, development and selection. Immunol. Rev. 175: 23-32. (Pubitemid 30427153)
33. Fallas, J. L., W. Yi, N. A. Draghi, H. M. O'Rourke, and L. K. Denzin. 2007. Expression patterns of H2-O in mouse B cells and dendritic cells correlate with cell function. J. Immunol. 178: 1488-1497. (Pubitemid 46156830)
34. Naruse, T. K., H. Kawata, H. Inoko, G. Isshiki, K. Yamano, M. Hino, and N. Tatsumi. 2002. The HLA-DOB gene displays limited polymorphism with only one amino acid substitution. Tissue Antigens 59: 512-519. (Pubitemid 35034471)
35. Theofilopoulos, A. N., and F. J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37: 269-390. (Pubitemid 15093080)
36. Hansen, A., F. Hiepe, and T. Dörner. 2007. Developments in lupus 2006. Arthritis Res. Ther. 9: 215.
37. Lauwerys, B. R., and E. K. Wakeland. 2005. Genetics of lupus nephritis. Lupus 14: 2-12. (Pubitemid 40216061)
38. Bolland, S., and J. V. Ravetch. 2000. Spontaneous autoimmune disease in Fc (gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity 13: 277-285.
39. Bolland, S., Y. S. Yim, K. Tus, E. K. Wakeland, and J. V. Ravetch. 2002. Genetic modifiers of systemic lupus erythematosus in FcgammaRIIB(2/2) mice. J. Exp. Med. 195: 1167-1174. (Pubitemid 34517142)
40. Bygrave, A. E., K. L. Rose, J. Cortes-Hernandez, J. Warren, R. J. Rigby, H. T. Cook, M. J. Walport, T. J. Vyse, and M. Botto. 2004. Spontaneous autoimmunity in 129 and C57BL/6 mice: implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2: E243.
41. Pape, K. A., V. Kouskoff, D. Nemazee, H. L. Tang, J. G. Cyster, L. E. Tze, K. L. Hippen, T. W. Behrens, and M. K. Jenkins. 2003. Visualization of the genesis and fate of isotype-switched B cells during a primary immune response. J. Exp. Med. 197: 1677-1687. (Pubitemid 36745343)
42. Draghi, N. A., and L. K. Denzin. 2010. H2-O, a MHC class II-like protein, sets a threshold for B-cell entry into germinal centers. Proc. Natl. Acad. Sci. USA 107: 16607-16612.
43. Rezaei, N., A. Aghamohammadi, S. D. Siadat, M. Moin, Z. Pourpak, M. Nejati, H. Ahmadi, S. Kamali, D. Norouzian, B. Tabaraei, and R. C. Read. 2008. Serum bactericidal antibody responses to meningococcal polysaccharide vaccination as a basis for clinical classification of common variable immunodeficiency. Clin. Vaccine Immunol. 15: 607-611. (Pubitemid 351967054)
44. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-196. (Pubitemid 40563168)
45. Alfonso, C., G. S. Williams, J. O. Han, J. A. Westberg, O. Winqvist, and L. Karlsson. 2003. Analysis of H2-O influence on antigen presentation by B cells. J. Immunol. 171: 2331-2337. (Pubitemid 37025539)
46. Alfonso, C., G. S. Williams, and L. Karlsson. 2003. H2-O influence on antigen presentation in H2-E-expressing mice. Eur. J. Immunol. 33: 2014-2021. (Pubitemid 37120874)
47. Kropshofer, H., A. B. Vogt, C. Thery, E. A. Armandola, B. C. Li, G. Moldenhauer, S. Amigorena, and G. J. Hämmerling. 1998. A role for HLADO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J. 17: 2971-2981. (Pubitemid 28254370)
48. Gondré-Lewis, T. A., A. E. Moquin, and J. R. Drake. 2001. Prolonged antigen persistence within nonterminal late endocytic compartments of antigen-specific B lymphocytes. J. Immunol. 166: 6657-6664. (Pubitemid 32467207)